Last reviewed · How we verify
The budesonide nasal irrigation
At a glance
| Generic name | The budesonide nasal irrigation |
|---|---|
| Sponsor | Siriraj Hospital |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Trial Evaluating the Efficacy of Local Budesonide Therapy in the Management of Hyposmia in COVID-19 Patients Without Signs of Severity (PHASE3)
- Nebulized Nasal Steroids (PHASE1, PHASE2)
- Anosmia Rehabilitation in Patients Post Coronavirus Disease (COVID 19) (PHASE4)
- Effectiveness of Mometasone Nasal Irrigation for Chronic Rhinosinusitis (PHASE4)
- Budesonide Nasal Irrigation Versus Fluticasone Propionate Nasal Spray in Treating Allergic Rhinitis Patients (PHASE4)
- The Effect of Modified Olfactory Training on Postoperative Olfactory Dysfunction in Patients With CRS (NA)
- Budesonide Irrigation in Allergic Rhinitis (PHASE4)
- The Impact of Airway Allergic Diseases on Children's and Parents' Quality of Life
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- The budesonide nasal irrigation CI brief — competitive landscape report
- The budesonide nasal irrigation updates RSS · CI watch RSS
- Siriraj Hospital portfolio CI